{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:42:57Z","timestamp":1694634177938},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1007\/bf02967641","type":"journal-article","created":{"date-parts":[[2008,10,7]],"date-time":"2008-10-07T06:54:48Z","timestamp":1223362488000},"page":"153-156","source":"Crossref","is-referenced-by-count":0,"title":["Anastrozole-Induced remission of diaphragmatic paralysis from metastatic breast cancer treated with multiple prior therapies"],"prefix":"10.1007","volume":"10","author":[{"given":"Takaomi","family":"Suzuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goro","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teiji","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02967641_CR1","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1200\/JCO.2001.19.18.3817","volume":"19","author":"A Goldhirsch","year":"2001","unstructured":"Goldhirsch A, Glick JH, Gelber RD,et al: Meeting highlights: Internalional Consensus Panel on the Trealment of Primary Breast Cancer. Seventh Internalional Conference on Adjuvant Therapy of Primary Breast Cancer.J Clin Oncol 19: 3817\u20133827, 2001.","journal-title":"J Clin Oncol"},{"key":"BF02967641_CR2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1524-4741.1999.98055.x","volume":"5","author":"AJ Knoche","year":"1999","unstructured":"Knoche AJ, Michaud LB, Buzdar AU: Efficacy of anastrozole in a consecutive series of advanced breast cancer palients trealed with multiple prior chemotherapies and endocrine agents: M.D. Anderson Cancer Center experience.Breast J 5: 176\u2013181, 1999.","journal-title":"Breast J"},{"key":"BF02967641_CR3","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1142::AID-CNCR13>3.0.CO;2-5","volume":"83","author":"AU Buzdar","year":"1998","unstructured":"Buzdar AU, Jonal W, Howell A,et al: Anastrozole versus megestrol acetale in the trealment of postmenopausal women with advanced breast carcinoma: results of a survival updale based on a combined analysis of dala from two malure phase III trials. Arimidex Study Group.Cancer 83: 1142\u20131152, 1998.","journal-title":"Cancer"},{"key":"BF02967641_CR4","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<730::AID-CNCR10>3.0.CO;2-0","volume":"79","author":"AU Buzdar","year":"1997","unstructured":"Buzdar AU, Jones SE, Vogel CL,et al: A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromalase inhibitor, with megestrol acetale in postmenopausal women with advanced breast carcinoma. Arimidex Study Group.Cancer 79: 730\u2013739, 1997.","journal-title":"Cancer"},{"key":"BF02967641_CR5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0959-8049(95)00014-3","volume":"32","author":"W Jonal","year":"1996","unstructured":"Jonal W, Howell A, Blomqvist C,et al: A randomized trial comparing two doses of the new selective aromalase inhibitor anastrozole (Arimidex) with megestrol acetale in postmenopausal palients with advanced breast cancer.Eur J Cancer 32: 404\u2013412, 1996.","journal-title":"Eur J Cancer"},{"key":"BF02967641_CR6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00682745","volume":"30","author":"PV Plourde","year":"1994","unstructured":"Plourde PV, Dyroff M, Dukes M: Arimidex: a potent and selective fourth-generalion aromalase inhibitor.Breast Cancer Res Treal 30: 103\u2013111, 1994.","journal-title":"Breast Cancer Res Treal"},{"key":"BF02967641_CR7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/00044011-200020050-00007","volume":"20","author":"Y Nomura","year":"2000","unstructured":"Nomura Y, Koyama H, Ohashi Y,et al: Clinical dosage determinalion of a new aromalase inhibitor, anastrozole, in postmenopausal Japanese women with advanced breast cancer.Clin Drug Invest 20: 357\u2013369, 2000.","journal-title":"Clin Drug Invest"},{"key":"BF02967641_CR8","first-page":"577","volume":"15","author":"H Koyama","year":"2000","unstructured":"Koyama H, Abe R, Tominaga T,et al: Clinical phase I trial for anastrozole: a new fourth generalion aromalase inhibitor.Jpn J Breast Cancer 15: 577\u2013583, 2000 (in Japanese).","journal-title":"Jpn J Breast Cancer"},{"key":"BF02967641_CR9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0272-5231(21)00504-9","volume":"9","author":"MJ Tobin","year":"1998","unstructured":"Tobin MJ: Respiralory muscles in disease.Clin Chest Med 9: 263\u2013286, 1998.","journal-title":"Clin Chest Med"},{"key":"BF02967641_CR10","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/014107688107401108","volume":"74","author":"CM Payne","year":"1981","unstructured":"Payne CM: Newly recognized syndrome in the neck: Homer\u2019s syndrome with ipsilaleral vocal cord and phrenic nerve palsies.J R Soc Med 74: 814\u2013818, 1981.","journal-title":"J R Soc Med"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02967641.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02967641\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02967641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:33Z","timestamp":1631923233000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02967641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["BF02967641"],"URL":"https:\/\/doi.org\/10.1007\/bf02967641","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}